Press Releases | Medtronic

Month Year

Email alerts

Jan 22, 2019

Patient-Level Survival Analysis Demonstrates No Link Between Paclitaxel Dose and Mortality in Patients Treated with IN.PACT Admiral DCB

Data Presented Today at LINC Reiterate Commitment to Patient Safety and Data Transparency

DUBLIN and LEIPZIG, Germany - January 22, 2019 - Medtronic plc (NYSE:MDT) today announced new data shared on the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in patients with peripheral...
Jan 17, 2019

Medtronic Enrolls First Patient in Clinical Study to Assess Pain Control and Oral Opioid Elimination with Targeted Drug Delivery

Study Will Further Advance Understanding of Effectiveness and Tolerability of the SynchroMed(TM) II Intrathecal Drug Delivery System in Patients Who Have Weaned off Oral Opioids

DUBLIN - January 17, 2019 - Medtronic plc (NYSE:MDT) today announced the first patient enrolled in the Embrace TDD (targeted drug delivery) clinical study that will evaluate the use of the...
Jan 15, 2019

Medtronic Launches Mobile App That Communicates Directly with World's First Smartphone-Connected Pacemakers

MyCareLink Heart(TM) Mobile App Allows Pacemaker Patients to Easily Stay Connected with Their Clinics

DUBLIN - January 15, 2019 - Medtronic plc (NYSE:MDT) today announced the launch of its MyCareLink Heart(TM) mobile app to support the world's first and only portfolio of pacemakers that can...
Jan 9, 2019

Medtronic Foundation Recognizes 12 Bakken Invitation Honorees For Driving Positive Change In Healthcare

Program Celebrates the Legacy of Medtronic Co-Founder Earl Bakken and Other Outstanding Patient Advocates Around the World

MINNEAPOLIS and Kona, Hawaii - January 9, 2019 - The Medtronic Foundation today announced 12 individuals from around the world as recipients of the 2018 Bakken Invitation. This Medtronic...
Jan 3, 2019

New Prediction Feature for Hypoglycemia Now Available in Sugar.IQ(TM) Personal Diabetes Assistant App, Developed by Medtronic and IBM Watson Health

IQcast Feature Aims to Predict the Likelihood of a Low Glucose Event Up to Four Hours in Advance

DUBLIN and CAMBRIDGE, Mass. - January 3, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, and its strategic technology partner, IBM (NYSE:IBM)...
Dec 28, 2018

Medtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference

DUBLIN - December 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37th Annual J.P. Morgan Healthcare Conference in San...
Dec 17, 2018

FDA Approves Smart Programmer for the InterStim System

Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence

DUBLIN - December 17, 2018 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the InterStim(TM) smart programmer for use with the InterStim system,...
Dec 10, 2018

Medtronic Named One of America's Best Corporate Citizens in 2018 by Forbes Magazine

DUBLIN - December 10, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has been named one of America's Most JUST Companies in 2018, according to Forbes...
Dec 7, 2018

Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2019

DUBLIN - December 7, 2018 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2019 third quarter cash dividend of $0.50 per ordinary share, representing a 9 percent...
Dec 4, 2018

Medtronic Announces Worldwide Voluntary Field Corrective Action; Company Issues Software Update for Puritan Bennett(TM) 980 (PB980) Ventilator Series

DUBLIN - December 4, 2018 - Medtronic (NYSE:MDT) is notifying customers worldwide of a voluntary field corrective action for its Puritan Bennett(TM) 980 (PB980) ventilator series. Medtronic...

Show per page